MARKET

GCTK

GCTK

Glucotrack
NASDAQ
0.8004
-0.0596
-6.93%
After Hours: 0.7909 -0.0095 -1.19% 19:59 05/08 EDT
OPEN
0.8327
PREV CLOSE
0.8600
HIGH
0.8500
LOW
0.7600
VOLUME
1.56M
TURNOVER
--
52 WEEK HIGH
15.90
52 WEEK LOW
0.6190
MARKET CAP
1.56M
P/E (TTM)
-0.0256
1D
5D
1M
3M
1Y
5Y
1D
GlucoTrack Files IDE for Implantable Glucose Monitor
TipRanks · 2d ago
GLUCOTRACK INC - SUBMITS IDE APPLICATION TO FDA FOR US CLINICAL STUDY OF IMPLANTABLE CBGM TECHNOLOGY - SEC FILING
Reuters · 2d ago
GlucoTrack submits IDE application to initiate study for CBGM technology
TipRanks · 3d ago
Glucotrack Submits FDA Investigational Device Exemption For U.S. Clinical Study Of Fully Implantable Continuous Blood Glucose Monitoring System
Benzinga · 3d ago
Glucotrack submits IDE application to FDA for US implantable glucose monitor study
PUBT · 3d ago
GLUCOTRACK ANNOUNCES IDE SUBMISSION FOR U.S. CLINICAL STUDY OF ITS NOVEL IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITORING TECHNOLOGY
Reuters · 3d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 4d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 4d ago
More
About GCTK
Glucotrack, Inc. is focused on the design, development, and commercialization of technologies for people with diabetes. The Company is engaged in developing a long-term Implantable Continuous Blood Glucose Monitor (CBGM) for people living with Type 1 diabetes and insulin-dependent Type 2 diabetes. Its CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. Its CBGM technology allows for a less burdensome approach to glucose monitoring. It has also completed four animal studies with evolving prototype systems, all four of which consistently demonstrated a simple implant procedure, functionality, and safety. The Company has also demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated a simple implant procedure, functionality, and safety.

Webull offers GlucoTrack Inc stock information, including NASDAQ: GCTK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GCTK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GCTK stock methods without spending real money on the virtual paper trading platform.